l-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study

BACKGROUND: l-carnitine is emerging as an item of interest for cardiovascular disease (CVD) prevention and treatment, but controversy exists. To examine the effectiveness and safety of l-carnitine, we assessed how genetically different levels of l-carnitine are associated with CVD risk and its risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jie V., Burgess, Stephen, Fan, Bohan, Schooling, C. Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434903/
https://www.ncbi.nlm.nih.gov/pubmed/36045366
http://dx.doi.org/10.1186/s12916-022-02477-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434903/
https://www.ncbi.nlm.nih.gov/pubmed/36045366
http://dx.doi.org/10.1186/s12916-022-02477-z

Ejemplares similares